-
Zelensky looks to close out Ukraine peace deal at Trump meet
-
MCG curator in 'state of shock' after Ashes Test carnage
-
Texans edge Chargers to reach NFL playoffs
-
Osimhen and Mane score as Nigeria win to qualify, Senegal draw
-
Osimhen stars as Nigeria survive Tunisia rally to reach second round
-
How Myanmar's junta-run vote works, and why it might not
-
Watkins wants to sicken Arsenal-supporting family
-
Arsenal hold off surging Man City, Villa as Wirtz ends drought
-
Late penalty miss denies Uganda AFCON win against Tanzania
-
Watkins stretches Villa's winning streak at Chelsea
-
Zelensky stops in Canada en route to US as Russia pummels Ukraine
-
Arteta salutes injury-hit Arsenal's survival spirit
-
Wirtz scores first Liverpool goal as Anfield remembers Jota
-
Mane rescues AFCON draw for Senegal against DR Congo
-
Arsenal hold off surging Man City, Wirtz breaks Liverpool duck
-
Arsenal ignore injury woes to retain top spot with win over Brighton
-
Sealed with a kiss: Guardiola revels in Cherki starring role
-
UK launches paid military gap-year scheme amid recruitment struggles
-
Jota's children join tributes as Liverpool, Wolves pay respects
-
'Tired' Inoue beats Picasso by unanimous decision to end gruelling year
-
Thailand and Cambodia declare truce after weeks of clashes
-
Netanyahu to meet Trump in US on Monday
-
US strikes targeted IS militants, Lakurawa jihadists, Nigeria says
-
Cherki stars in Man City win at Forest
-
Schwarz records maiden super-G success, Odermatt fourth
-
Russia pummels Kyiv ahead of Zelensky's US visit
-
Smith laments lack of runs after first Ashes home Test loss for 15 years
-
Russian barrage on Kyiv kills one, leaves hundreds of thousands without power
-
Stokes, Smith agree two-day Tests not a good look after MCG carnage
-
Stokes hails under-fire England's courage in 'really special' Test win
-
What they said as England win 4th Ashes Test - reaction
-
Hong Kongers bid farewell to 'king of umbrellas'
-
England snap 15-year losing streak to win chaotic 4th Ashes Test
-
Thailand and Cambodia agree to 'immediate' ceasefire
-
Closing 10-0 run lifts Bulls over 76ers while Pistons fall
-
England 77-2 at tea, need 98 more to win chaotic 4th Ashes Test
-
Somalia, African nations denounce Israeli recognition of Somaliland
-
England need 175 to win chaotic 4th Ashes Test
-
Cricket Australia boss says short Tests 'bad for business' after MCG carnage
-
Russia lashes out at Zelensky ahead of new Trump talks on Ukraine plan
-
Six Australia wickets fall as England fight back in 4th Ashes Test
-
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
-
Dental Implant Financing and Insurance Options in Georgetown, TX
-
Man Utd made to 'suffer' for Newcastle win, says Amorim
-
Morocco made to wait for Cup of Nations knockout place after Egypt advance
-
Key NFL week has playoff spots, byes and seeds at stake
-
Morocco forced to wait for AFCON knockout place after Mali draw
-
Dorgu delivers winner for depleted Man Utd against Newcastle
-
US stocks edge lower from records as precious metals surge
-
Somalia denounces Israeli recognition of Somaliland
Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
P.Martin--AMWN